C

Caroline Robert

Institut Gustave Roussy

ORCID: 0000-0002-9493-0238

Publishes on Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways, Cutaneous Melanoma Detection and Management. 1.5k papers and 159.9k citations.

PubIndex Score98Top 2%How it's scored

1.5kPublications

159.9kTotal Citations

First publication: 1993First senior author: 1997

Cancer Immunotherapy and Biomarkers Melanoma and MAPK Pathways Cutaneous Melanoma Detection and Management CAR-T cell therapy research Immunotherapy and Immune Responses

Top publicationsby citations

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

Paul B. Chapman, Grant A. McArthur, Axel Hauschild et al.|New England Journal of Medicine|2011

Cited by 7.7k

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Caroline Robert, Antoni Ribas|New England Journal of Medicine|2015

Cited by 5.8k

Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation

Caroline Robert, Paolo A. Ascierto, Georgina V. Long et al.|New England Journal of Medicine|2014

Cited by 5.3k

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

Alexander M.M. Eggermont, Caroline Robert|New England Journal of Medicine|2018

Cited by 1.8k

Adjuvant Dabrafenib plus Trametinib in Stage III<i>BRAF</i>-Mutated Melanoma

Georgina V. Long, John M. Kirkwood, Axel Hauschild et al.|New England Journal of Medicine|2017

Cited by 1.5k